Also given our weak, but trending correlation between expression of FLNA and CASR or FLNA and certain transcription factors in human AML cells, therapeutic inhibition of FLNA raises hopes for innovative, adjunct therapies in AML. This evidence concerns the gene CASR and acute myeloid leukemia.